Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet–induced insulin resistance
Yasuo Terauchi, … , Ryozo Nagai, Takashi Kadowaki
Yasuo Terauchi, … , Ryozo Nagai, Takashi Kadowaki
Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):246-257. https://doi.org/10.1172/JCI17645.
View: Text | PDF
Research Article Article has an altmetric score of 2

Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet–induced insulin resistance

  • Text
  • PDF
Abstract

Glucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of β cell–specific Gck (Gck+/–) causes impaired insulin secretion to glucose, although the animals have a normal β cell mass. When fed a high-fat (HF) diet, wild-type mice showed marked β cell hyperplasia, whereas Gck+/– mice demonstrated decreased β cell replication and insufficient β cell hyperplasia despite showing a similar degree of insulin resistance. DNA chip analysis revealed decreased insulin receptor substrate 2 (Irs2) expression in HF diet–fed Gck+/– mouse islets compared with wild-type islets. Western blot analyses confirmed upregulated Irs2 expression in the islets of HF diet–fed wild-type mice compared with those fed standard chow and reduced expression in HF diet–fed Gck+/– mice compared with those of HF diet–fed wild-type mice. HF diet–fed Irs2+/– mice failed to show a sufficient increase in β cell mass, and overexpression of Irs2 in β cells of HF diet–fed Gck+/– mice partially prevented diabetes by increasing β cell mass. These results suggest that Gck and Irs2 are critical requirements for β cell hyperplasia to occur in response to HF diet–induced insulin resistance.

Authors

Yasuo Terauchi, Iseki Takamoto, Naoto Kubota, Junji Matsui, Ryo Suzuki, Kajuro Komeda, Akemi Hara, Yukiyasu Toyoda, Ichitomo Miwa, Shinichi Aizawa, Shuichi Tsutsumi, Yoshiharu Tsubamoto, Shinji Hashimoto, Kazuhiro Eto, Akinobu Nakamura, Mitsuhiko Noda, Kazuyuki Tobe, Hiroyuki Aburatani, Ryozo Nagai, Takashi Kadowaki

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 3 5 7 5 8 9 6 7 8 14 15 13 13 11 15 7 10 6 3 165
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2011 (15)

Title and authors Publication Year
Growth hormone receptor mediates β−cells hyperplasia and glucose-stimulated insulin secretion in obese mice
Yingjie Wu, Chengyu Liu, Hui Sun, Archana Vijayakumar, pejman raeisi giglou, Ruifang Qiao, Joshua Oppenheimer, shoshana yakar, Derek LeRoith
Journal of Clinical Investigation 2011
Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators
D Fenner, S Odili, HK Hong, Y Kobayashi, A Kohsaka, SM Siepka, MH Vitaterna, P Chen, B Zelent, J Grimsby, JS Takahashi, FM Matschinsky, J Bass
The Journal of biological chemistry 2011
Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA
D Stefanovski, JM Richey, O Woolcott, M Lottati, D Zheng, LN Harrison, V Ionut, SP Kim, I Hsu, RN Bergman
PloS one 2011
Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
J Shirakawa, H Fujii, K Ohnuma, K Sato, Y Ito, M Kaji, E Sakamoto, M Koganei, H Sasaki, Y Nagashima, K Amo, K Aoki, C Morimoto, E Takeda, Y Terauchi
Diabetes 2011
Rictor/mTORC2 Is Essential for Maintaining a Balance Between  -Cell Proliferation and Cell Size
Y Gu, J Lindner, A Kumar, W Yuan, MA Magnuson
Diabetes 2011
Control of Pancreatic β Cell Regeneration by Glucose Metabolism
S Porat, N Weinberg-Corem, S Tornovsky-Babaey, R Schyr-Ben-Haroush, A Hija, M Stolovich-Rain, D Dadon, Z Granot, V Ben-Hur, P White, CA Girard, R Karni, KH Kaestner, FM Ashcroft, MA Magnuson, A Saada, J Grimsby, B Glaser, Y Dor
Cell Metabolism 2011
Disruption of a Novel Kruppel-like Transcription Factor p300-regulated Pathway for Insulin Biosynthesis Revealed by Studies of the c.-331 INS Mutation Found in Neonatal Diabetes Mellitus
A Bonnefond, G Lomberk, N Buttar, K Busiah, E Vaillant, S Lobbens, L Yengo, A Dechaume, B Mignot, A Simon, R Scharfmann, B Neve, S Tanyolaç, U Hodoglugil, F Pattou, H Cavé, J Iovanna, R Stein, M Polak, M Vaxillaire, P Froguel, R Urrutia
The Journal of biological chemistry 2011
Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation
E Hakonen, J Ustinov, I Mathijs, J Palgi, L Bouwens, PJ Miettinen, T Otonkoski
Diabetologia 2011
Inducible Nitric-oxide Synthase and Nitric Oxide Donor Decrease Insulin Receptor Substrate-2 Protein Expression by Promoting Proteasome-dependent Degradation in Pancreatic β-Cells
T Tanioka, Y Tamura, M Fukaya, S Shinozaki, J Mao, M Kim, N Shimizu, T Kitamura, M Kaneki
The Journal of biological chemistry 2011
Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes*
J Shirakawa, K Amo, H Ohminami, K Orime, Y Togashi, Y Ito, K Tajima, M Koganei, H Sasaki, E Takeda, Y Terauchi
The Journal of biological chemistry 2011
Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance
K Masuda, K Aoki, Y Terauchi
Journal of Diabetes Investigation 2011
Effect of long-term treatment with a small-molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function
A Nakamura, H Shimazaki, S Ohyama, J Eiki, Y Terauchi
Journal of Diabetes Investigation 2011
Glucokinase Activators for Diabetes Therapy: May 2010 status report
FM Matschinsky, B Zelent, N Doliba, C Li, JM Vanderkooi, A Naji, R Sarabu, J Grimsby
Diabetes care 2011
Specific Glucose-Induced Control of Insulin Receptor Substrate-2 Expression Is Mediated via Ca2+-Dependent Calcineurin/NFAT Signaling in Primary Pancreatic Islet  -Cells
D Demozay, S Tsunekawa, I Briaud, R Shah, CJ Rhodes
Diabetes 2011
Exendin-4 regulates the expression of the ATP-binding cassette transporter A1 via transcriptional factor PREB in the pancreatic β cell line
Y Miyai, K Murao, H Imachi, J Li, Y Nishiuchi, H Masugata, H Iwama, Y Kushida, T Ishida, R Haba
Journal of Endocrinological Investigation 2011

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
103 readers on Mendeley
See more details